1. Settlement Ends Fight at Arcturus Therapeutics; New Board Named

    Settlement Ends Fight at Arcturus Therapeutics; New Board Named

    The San Diego RNA drug developer Arcturus Therapeutics (NASDAQ: ARCT) named four new board members Tuesday, after the four directors who ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned